Virginia provider taps McKesson for IT suite

Sarah Lamberti | | Health Imaging | Practice Management
The Chesapeake Hospital Authority in Virginia has selected McKesson to provide an EMR, an automated medication management process and integrated revenue management capabilities at Chesapeake Regional Medical Center.

"This new system will allow us to continue improving our clinical quality, patient safety and quality initiatives," said Christopher Mosley, Chesapeake Regional's president and CEO.

The medical center also will implement McKesson's revenue management solution to automate operational and financial processes, according to the company

Chesapeake Regional Medical Center is a 310-bed healthcare facility in Chesapeake, Va., that serves southeastern Virginia and northeastern North Carolina.



Sarah Lamberti

Related Content

Clinicians want AI to show its work
Multidose contrast injectors could increase waste in some radiology departments
Imaging leaders share 7 key considerations for remote scanning programs
Policies and regulations shaping radiology in 2025
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care

Around the web

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.